Becton, Dickinson, and Company (BDX) , popularly known as BD, completed its acquisition of Edwards Lifesciences Corporation (EW) Critical Care product group, renaming it BD Advanced Patient Monitoring.BD had announced a $4.2 billion deal to acquire Edwards Lifesciences' Critical Care product group in June. The acquisition strengthens BD’s portfolio of advanced monitoring solutions with AI-enabled clinical decision tools. The acquired business also has a strong innovation pipeline that is poised to drive inn ...